The online discussion panel includes:
- Daniel Erlanson, President (Carmot Therapeutics)
- Jeff Blaney, Director Computational Chemistry & Chemoinformatics (Genentech)
- Henry Johnson, Senior Scientist (Amgen, Onyx Pharmaceuticals subsidiary)
- Mark Gurney, CEO (Tetra Discovery Partners)
- Shirley Louise-May, CDD Advocate (ex-Pfizer)
Register now to reserve your spot in this discussion.
You can read more and share via email or the social media links online here.